Eiger Biopharmaceuticals, Inc. (EIGR) Stockholder News: Lead Plaintiff Deadline is Fast Approaching; Contact Robbins LLP for More Information
December 12, 2022 17:06 ET
|
Robbins LLP
SAN DIEGO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...
Eiger Biopharmaceuticals, Inc. (EIGR) Equity Notice: Contact Robbins LLP if You Incurred Significant Damages From Your Investment in Eiger Biopharmaceuticals, Inc.
November 28, 2022 17:00 ET
|
Robbins LLP
SAN DIEGO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...
Eiger BioPharmaceuticals Investors: Please contact the Portnoy Law Firm to recover your losses, January 9, 2023 deadline
November 28, 2022 13:03 ET
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 28, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Eiger BioPharmaceuticals,...
Eiger Biopharmaceutials, Inc. (EIGR) Class Action Notice: Contact Robbins LLP For Information if Eiger Biopharmaceutials, Inc. Harmed Your Financial Interests
November 22, 2022 13:01 ET
|
Robbins LLP
SAN DIEGO, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...
Eiger Biopharmaceutials, Inc. (EIGR) Shareholder Update: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Eiger Biopharmaceutials, Inc.
November 17, 2022 13:34 ET
|
Robbins LLP
SAN DIEGO, Nov. 17, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...
Eiger Biopharmaceuticals, Inc. (EIGR) Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Eiger Biopharmaceuticals, Inc.
November 11, 2022 19:29 ET
|
Robbins LLP
SAN DIEGO, Nov. 11, 2022 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise...